Ofloxacin should not be used in individuals with myasthenia gravis since it can maximize muscle weak point. Neurotoxicity, ototoxicity and nephrotoxicity have transpired in sufferers receiving systemic aminoglycoside therapy. Aminoglycosides may perhaps aggravate muscle mass weakness in clients with acknowledged or suspected neuromuscular Issues, for example myasthenia gravis or https://everettb974tai1.blogspothub.com/profile